Search Results

There are 24260 results for: content related to: Nocturnal subcutaneous apomorphine infusion in Parkinson's disease and restless legs syndrome

  1. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 30, Issue S1, June 2015, Pages: S1–S567,

    Version of Record online : 12 JUN 2015, DOI: 10.1002/mds.26295

  2. Abstracts of The Movement Disorder Society's Twelfth International Congress of Parkinson's Disease and Movement Disorders

    Movement Disorders

    Volume 23, Issue S1, 15 May 2008, Pages: S1–S422,

    Version of Record online : 28 MAY 2008, DOI: 10.1002/mds.22133

  3. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 29, Issue S1, May 2014, Pages: S1–S571,

    Version of Record online : 6 JUN 2014, DOI: 10.1002/mds.25914

  4. Apomorphine: An underutilized therapy for Parkinson's disease

    Movement Disorders

    Volume 15, Issue 5, September 2000, Pages: 789–794, Werner Poewe and Gregor K. Wenning

    Version of Record online : 23 JAN 2001, DOI: 10.1002/1531-8257(200009)15:5<789::AID-MDS1005>3.0.CO;2-H

  5. DA agonists - Non-Ergot derivaties: Apomorphine

    Movement Disorders

    Volume 17, Issue S4, July/August 2002, Pages: S83–S89,

    Version of Record online : 29 JUL 2002, DOI: 10.1002/mds.5567

  6. You have free access to this content
    A study of tolerance to apomorphine

    British Journal of Pharmacology

    Volume 117, Issue 5, March 1996, Pages: 781–786, Jean-Louis Montastruc, Marie-Elise Llau, Jean-Michel Senard, Marie-Antoinette Tran, Olivier Rascol and Paul Montastruc

    Version of Record online : 19 JUL 2012, DOI: 10.1111/j.1476-5381.1996.tb15260.x

  7. Continuous Subcutaneous Apomorphine Infusion Improves Severe Restless Legs Syndrome

    Movement Disorders Clinical Practice

    Volume 1, Issue 3, September 2014, Pages: 233–234, Thomas Müller, Marion Marg, Hartmut Rothe and Matthias Küchler

    Version of Record online : 4 JUN 2014, DOI: 10.1002/mdc3.12039

  8. Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: Long-term follow-up study of 64 patients

    Movement Disorders

    Volume 17, Issue 6, November/December 2002, Pages: 1235–1241, Alice J. Manson, Kirsten Turner and Andrew J. Lees

    Version of Record online : 23 JUL 2002, DOI: 10.1002/mds.10281

  9. Apomorphine infusional therapy in parkinson's disease: Clinical utility and lack of tolerance

    Movement Disorders

    Volume 10, Issue 1, January 1995, Pages: 37–43, Dr. Stephen T. Gancher, John G. Nutt and William R. Woodward

    Version of Record online : 12 OCT 2004, DOI: 10.1002/mds.870100108

  10. Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: A prospective study using single-dose challenges

    Movement Disorders

    Volume 20, Issue 2, February 2005, Pages: 151–157, Regina Katzenschlager, Andrew Hughes, Andrew Evans, Alice J. Manson, Marion Hoffman, Lesley Swinn, Hilary Watt, Kailash Bhatia, Niall Quinn and Andrew J. Lees

    Version of Record online : 10 SEP 2004, DOI: 10.1002/mds.20276

  11. You have free access to this content
    Abstracts

    Movement Disorders

    Volume 32, Issue S2, June 2017, Pages: S1–S627,

    Version of Record online : 2 JUN 2017, DOI: 10.1002/mds.27087

  12. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Version of Record online : 19 JUN 2012, DOI: 10.1002/mds.25051

  13. You have free access to this content
    Modulation of secretion by dopamine involves decreases in calcium and nicotinic currents in bovine chromaffin cells.

    The Journal of Physiology

    Volume 427, Issue 1, August 1, 1990, Pages: 495–517, J M Sontag, P Sanderson, M Klepper, D Aunis, K Takeda and M F Bader

    Version of Record online : 1 AUG 1990, DOI: 10.1113/jphysiol.1990.sp018184

  14. Ontogeny of apomorphine-induced stereotypy and its D1 and D2 receptor mediation in rats depleted of dopamine as neonates

    Developmental Psychobiology

    Volume 25, Issue 7, November 1992, Pages: 475–495, Dalia R. Abrams and Dr. John P. Bruno

    Version of Record online : 13 OCT 2004, DOI: 10.1002/dev.420250703

  15. You have free access to this content
    Poster Session

    Movement Disorders

    Volume 31, Issue S2, June 2016, Pages: S1–S697,

    Version of Record online : 19 JUN 2016, DOI: 10.1002/mds.26688

  16. Oral apomorphine delivery from solid lipid nanoparticleswith different monostearate emulsifiers: Pharmacokinetic and behavioral evaluations

    Journal of Pharmaceutical Sciences

    Volume 100, Issue 2, February 2011, Pages: 547–557, Ming-Jun Tsai, Yaw-Bin Huang, Pao-Chu Wu, Yaw-Syan Fu, Yao-Ren Kao, Jia-You Fang and Yi-Hung Tsai

    Version of Record online : 25 AUG 2010, DOI: 10.1002/jps.22285

  17. Diagnostic and therapeutic value of apomorphine in Parkinsonian patients

    International Journal of Clinical Practice

    Volume 58, Issue 11, November 2004, Pages: 1028–1032, J.C. Sharma, 1 L. Macnamara, 1 M. Hasoon and 1 M. Vassallo 2

    Version of Record online : 24 NOV 2004, DOI: 10.1111/j.1368-5031.2004.00357.x

  18. You have free access to this content
    Examination of the safety and use of apomorphine prescribed in general practice in England as a treatment for erectile dysfunction

    BJU International

    Volume 98, Issue 1, July 2006, Pages: 125–131, KARYN M. MACLENNAN, ANDREW BOSHIER, LYNDA V. WILTON and SAAD A.W. SHAKIR

    Version of Record online : 8 JUN 2006, DOI: 10.1111/j.1464-410X.2006.06253.x

  19. A double-blind, placebo-controlled study of intranasal apomorphine spray as a rescue agent for off-states in Parkinson's disease

    Movement Disorders

    Volume 13, Issue 5, September 1998, Pages: 782–787, Richard B. Dewey Jr, Demetrius M. Maraganore, J. Eric Ahlskog and Joseph Y. Matsumoto

    Version of Record online : 4 NOV 2004, DOI: 10.1002/mds.870130505

  20. Neurochemical correlates of behavioral sensitization following repeated apomorphine treatment: Assessment of the role of D1 dopamine receptor stimulation

    Synapse

    Volume 14, Issue 2, June 1993, Pages: 160–168, James K. Rowlett, Bruce A. Mattingly and Michael T. Bardo

    Version of Record online : 12 OCT 2004, DOI: 10.1002/syn.890140209